Archived entries before July 2003 can also be found here (pharmaceuticals) and here (vaccines).
Pharmaceuticals, 2003: “‘Diet drug litigation leads to fat fees’” (fen-phen, ephedra), May 30-Jun. 1; “Courtroom assault on drugmakers“, May 27; “Mississippi investigation heats up“, May 7; “Jury clears Bayer in cholesterol-drug case“, Mar. 19; “New Medicare drug benefit? Link it to product liability reform“, Mar. 10-11. 2002: “Fen-phen settlement abuses: the plot thickens“, Sept. 27-29 (& Dec. 16-17, 2002, Feb. 25-26, 2002, Dec. 28, 2001, Aug. 18, 1999); “Ignominious wind-down to Norplant campaign“, Sept. 9-10 (& Aug. 11 & Aug. 27, 1999); “You mean I’m suing that nice doctor?” (Propulsid), Aug. 1 (& see Sept. 6-8); “‘Tampa Taliban’ mom blames acne drug“, Apr. 18 (& Feb. 1-3); “Pharmaceutical roundup” (fen-phen, contraceptive Pill, Viagra, psychiatric drugs), Apr. 16-17; “‘Can pain treatment survive our addiction to law?’” (OxyContin), Apr. 10 (& Aug. 27, May 30, Jan. 23-24, 2002, Aug. 7-8, July 25, 2001)(& letter to the editor, Apr. 11); “Omit a peripheral defendant, get sued for legal malpractice” (tetracycline), Feb. 15-17; “‘Companies may be liable for drugs used in rapes’“, Jan. 25-27. 2001: “Texas jury clears drugmaker in first Rezulin case“, Dec. 19 (& update Jan. 9-10, 2002: it loses second trial); “For client-chasers, daytime TV gets results“, Dec. 18; “Bioterror unpreparedness“, Nov. 28; “Cipro side effects? Sue!“, Nov. 1; “Suit blames drugmaker for Columbine“, Oct. 24-25; “‘Plaintiff’s lawyers going on defense’” (Scruggs represents Sulzer Orthopedics), Oct. 9; “Propulsid verdict; ‘Robbery on Highway 61’“, Oct. 1; “Antidepressant blamed for killing spree” (Paxil), June 13; “Mississippi’s forum-shopping capital” (Fayette), May 4-6 (& see June 22-24 (Amity Shlaes)); “Anti-Ritalin lawyers still acting out“, Apr. 13-15 (& Sept. 18, Sept. 22-24, 2000); “Target: Alka-Seltzer” (PPA), Apr. 6-8 (& see Sept. 10); “The malaria drug made him do it“, Mar. 28. 2000: “Turn of the screw” (pedicle screw lawsuits), Oct. 24 (& see “Fee fights“, Aug. 2, 2001); “‘Controversial drug makes a comeback’” (Bendectin may be reintroduced in U.S.), Sept. 27-28 (& July 21, 1999); “Australian roundup” (Copper-7 IUD), Sept. 6-7; “‘Lilly’s legal strategy disarmed Prozac lawyers’“, May 8. 1999: “World according to Ron Motley” (drugmakers among next targets of earth’s richest lawyer), Nov. 1; “Rhode Island A.G.: let’s do latex gloves next“, Oct. 26.
Breast implants, 2002: “Pharmaceutical roundup” (silicone implants popular in Canada), Apr. 16-17. 2001: “Fee fights“, Aug. 2. 2000: “O’Quinn a top Gore recount angel“, Dec. 15-17; “‘Hush — good news on silicone’“, Nov. 29; “No breast cancer link“, Oct. 23; “From our mail sack: hyperactive lawyers“, Sept. 22-24; Feds file Medicare recoupment lawsuit over silicone implants“, April 6; “Study shows breast implants pose little risk“, March 20. 1999: “No spotlight on me, thanks” (John O’Quinn obtains gag order against lawyers for dissatisfied clients), August 4; “Never saying you’re sorry”, July 2.
Vaccines: “Trial lawyers vs. thimerosal“, Dec. 20-22, 2002 (& Jun. 18-19, 2003); “Vaccine industry perennially in court“, Nov. 7-8, 2001; “Lawsuit fears slow bioterror vaccines“, Oct. 22; “Study: DPT and MMR vaccines not linked to brain injury“, Aug. 31-Sept. 2, 2001; “Vaccine compensation and its discontents“, Nov. 13, 2000.
Other links: Breast implants:
Gina Kolata, “Panel Confirms No Major Illness Tied To Breast Implants”, New York Times, June 21, 1999.
National Institute of Medicine 1999 study
Reason magazine “Breaking Issues”
Food and Drug Administration update
Breast Implant Litigation Page (Prof. David Bernstein, George Mason U.)
Marcia Angell, “Science on Trial: Medical Evidence and the Law in the Breast Implant Case“, Manhattan Institute Civil Justice Memo, August 1996.
Walter Olson, review of Marcia Angell, “Science on Trial” (National Review, November 11, 1996)
Other links: Contraceptives:
Marc Arkin, “Products Liability and the Threat to Contraception” (Manhattan Institute Civil Justice Memo, February 1999).
Comments are closed.